ATHEROMED
AtheroMed, Inc. develops treatments for peripheral arterial disease. The company was incorporated in 2006 and is headquartered in Menlo Park, California.
ATHEROMED
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2006-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.atheromedinc.com
Total Employee:
11+
Status:
Active
Contact:
650-473-6846
Total Funding:
43.71 M USD
Technology used in webpage:
Canadian Server Location
Similar Organizations
Equinox
Equinox is a developer of a medical technology in revolutionizing the treatment of glaucoma and other progressive eye diseases.
G Medical Innovations
G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
NuPulseCV
NuPulse specializes in developing technology designed to treat patients with heart failure.
Current Advisors List
Board_member
Board_member
Board_member
Founder
Investors List
The Vertical Group
The Vertical Group investment in Private Equity Round - AtheroMed
Kaiser Permanente Ventures
Kaiser Permanente Ventures investment in Private Equity Round - AtheroMed
U.S. Venture Partners
U.S. Venture Partners investment in Private Equity Round - AtheroMed
Canaan Partners
Canaan Partners investment in Private Equity Round - AtheroMed
The Vertical Group
The Vertical Group investment in Private Equity Round - AtheroMed
U.S. Venture Partners
U.S. Venture Partners investment in Series D - AtheroMed
Canaan Partners
Canaan Partners investment in Series D - AtheroMed
Kaiser Permanente Ventures
Kaiser Permanente Ventures investment in Series D - AtheroMed
U.S. Venture Partners
U.S. Venture Partners investment in Series A - AtheroMed
Official Site Inspections
http://www.atheromedinc.com
- Host name: 104.247.81.54
- IP address: 104.247.81.54
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "AtheroMed"
AtheroMed - Crunchbase Company Profile & Funding
Organization. AtheroMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email info@atheromedinc.com; Phone …See details»
Atheromed Company Profile 2024: Valuation, Investors ... - PitchBook
Atheromed General Information Description. Developer of catheter-based medical devices intended for the treatment of peripheral artery disease (PAD). The system is designed to treat …See details»
AtheroMed Inc - Company Profile and News - Bloomberg Markets
Company profile page for AtheroMed Inc including stock price, company news, executives, board members, and contact informationSee details»
AtheroMed - Overview, News & Similar companies | ZoomInfo.com
AtheroMed, Inc., a privately-held medical device company based in Menlo Park, California, is dedicated to developing innovative technology for trea ting peripheral artery disease to quickly, …See details»
AtheroMed, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Aug 24, 2023 Explore AtheroMed, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news.See details»
Volcano Corporation Snags AtheroMed, Inc. For $115 Million Cash
May 29, 2014 AtheroMed, Inc., a privately-held medical device company based in Menlo Park, CA, is dedicated to developing innovative technology for treating peripheral artery disease to …See details»
AtheroMed - Contacts, Employees, Board Members, Advisors
AtheroMed is engaged in developing the peripheral atherectomy catheter system to enhance the treatment of below the knee disease.See details»
Volcano Buys AtheroMed to Expand PAD Offerings - MDDI Online
May 29, 2014 In a move to broaden its holdings and diversify its product portfolio, Volcano Corp. (San Diego, CA) has announced that it has entered into an agreement to purchase privately …See details»
AtheroMed - Funding, Financials, Valuation & Investors
AtheroMed is engaged in developing the peripheral atherectomy catheter system to enhance the treatment of below the knee disease.See details»
AtheroMed - Products, Competitors, Financials, Employees, …
AtheroMed is developing an approach in the endovascular treatment of peripheral arterial blood vessels that become obstructed due to plaque and thrombus and require re-vascularization. …See details»
Volcano To Acquire Atherectomy Device Maker …
Intravascular imaging and precision guided therapeutic device company Volcano Corp. recently signed an agreement to acquire AtheroMed, manufacturer of the FDA-approved Phoenix device for treatment of peripheral artery disease (PAD).See details»
Volcano Corporation announces agreement to acquire AtheroMed
May 28, 2014 Under terms of the agreement, Volcano will pay US$115 million in cash at closing, which is expected to occur in the current quarter. In addition, Volcano will make a US$15 …See details»
AtheroMed Announces FDA Clearance To Market The Phoenix …
Jan 27, 2014 AtheroMed, Inc., a privately-held medical device company based in Menlo Park, California, is dedicated to developing innovative technology for treating peripheral artery …See details»
Volcano Corporation Announces Agreement To Acquire …
AtheroMed, Inc., a privately-held medical device company based in Menlo Park, CA, is dedicated to developing innovative technology for treating peripheral artery disease to quickly, safely and …See details»
Volcano to Acquire AtheroMed - Endovascular Today
May 27, 2014—Volcano Corporation announced that it has signed an agreement to acquire AtheroMed, Inc., a privately held company that has developed the Phoenix atherectomy …See details»
Volcano to Buy AtheroMed - Yahoo Finance
May 28, 2014 Volcano Corporation (VOLC) signed an agreement to acquire privately-held AtheroMed, Inc.See details»
FDA Clears AtheroMed's Phoenix Atherectomy System® for …
Jan 29, 2014 California based, AtheroMed, Inc., develops innovative technology for treating peripheral artery disease to quickly, safely, and effectively restore blood flow. In so doing its …See details»
FDA clearance to market Phoenix Atherectomy System
Jan 29, 2014 Menlo Park, Calif. - AtheroMed, a developer of catheter technologies for treating peripheral artery disease (PAD), has received FDA clearance to market the Phoenix …See details»
Volcano AtheroMed, Inc. Jean Chang Senior Director, Operations
Volcano AtheroMed, Inc. 1530 O'Brien Drive, Suite A. Menlo Park, CA 94025 Jean Chang Sr Director, Operations Phone: (650) 352 5255 Peripheral Atherectomy Catheter Intraluminal …See details»
Volcano closes $117M AtheroMed buy - MassDevice
Jun 18, 2014 Volcano (NSDQ:VOLC) said yesterday that it closed the buyout of AtheroMed and its Phoenix atherectomy catheter system, paying out roughly $116.5 million in cash but netting …See details»